As of 2026-03-19, the Intrinsic Value of Newscope Capital Corporation (PHRM.CN) is -0.41 CAD. This PHRM.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.07 CAD, the upside of Newscope Capital Corporation is -691.44%.
Based on its market price of 0.07 CAD and our intrinsic valuation, Newscope Capital Corporation (PHRM.CN) is overvalued by 691.44%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.41 - -0.41 | -0.41 | -691.44% |
| P/E | (0.01) - (0.10) | (0.01) | -117.7% |
| DDM - Stable | (0.13) - (0.85) | (0.49) | -804.7% |
| DDM - Multi | (0.07) - (0.37) | (0.12) | -269.3% |
| Market Cap (mil) | 6.20 |
| Beta | -0.37 |
| Outstanding shares (mil) | 88.52 |
| Enterprise Value (mil) | 5.49 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.28% |
| Cost of Debt | 5.00% |
| WACC | 6.48% |